Artelo Biosciences, Inc. (ARTL) Ownership
ARTL ownership summary
as of October 17, 2026- Institutions
- 2.4% of shares outstanding
- Insiders
- 0.11% of shares outstanding
- Shares outstanding
- 548K
- Float
- 510K shares available to trade
- Short interest
- 8.43% 46K shares short
- Days to cover
- 0.04 short interest up 104.7% vs prior month
- Institutions 2.38%
- Insiders 0.11%
- Other investors 97.52%
ARTL top institutional holders
18 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Jane Street Group LLC | 1.35% | 66K | $179,121 | +53,262 (+407.2%) | June 30, 2026 |
| 2 | Geode Capital Management, LLC | 0.28% | 14K | $37,433 | +13,864 (0.0%) | June 30, 2026 |
| 3 | StoneX Group Inc | 0.25% | 12K | $33,480 | +12,400 (0.0%) | June 30, 2026 |
| 4 | Vanguard Capital Management, LLC | 0.21% | 10K | $27,348 | — | June 30, 2026 |
| 5 | Tower Research Capital LLC | 0.17% | 8,435 | $22,774 | +5,609 (+198.5%) | June 30, 2026 |
| 6 | Vanguard Fiduciary Trust Co | 0.06% | 3,139 | $8,475 | — | June 30, 2026 |
| 7 | UBS Group AG | 0.06% | 2,804 | $7,571 | +2,804 (0.0%) | June 30, 2026 |
| 8 | TD Waterhouse Canada Inc | 0.00% | 2 | $5 | +2 (0.0%) | June 30, 2026 |
| 9 | Rothschild Wealth Partners | 0.00% | 2 | $5 | — | June 30, 2026 |
| 10 | Danske Bank A/S. | 0.00% | 1 | $3 | +1 (0.0%) | June 30, 2026 |
| 11 | CWM, LLC duplicate | 0.00% | 1 | $3 | +1 (0.0%) | March 31, 2026 |
| 12 | Citigroup Inc | 0.00% | — | — | −3,076 (−100.0%) | June 30, 2026 |
| 13 | Kathmere Capital Management, LLC | 0.00% | — | — | −13,250 (−100.0%) | June 30, 2026 |
| 14 | Clear Street Group Inc | 0.00% | — | — | −100 (−100.0%) | June 30, 2026 |
| 15 | Two Sigma Investments LLC | 0.00% | — | — | −20,669 (−100.0%) | March 31, 2026 |
| 16 | Virtu Financial LLC | 0.00% | — | — | −16,865 (−100.0%) | March 31, 2026 |
| 17 | Advisor Group Holdings, Inc. | 0.00% | — | — | −1 (−100.0%) | June 30, 2026 |
| 18 | Bank of America Corp | 0.00% | — | — | −17 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 18, 8 holders added 88K shares and 7 cut 54K.
ARTL top mutual fund and ETF holders
2 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.03% | 1,476 | $3,985 | −1 (−0.1%) | August 31, 2026 |
| 2 | Fidelity Series Total Market Index | <0.01% | 25 | $68 | −1 (−3.8%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ARTL insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2022-08-11 | Gregory D Gorgas | Buy | $24.18 | 200 | $4,836 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
ARTL shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ARTL
Institutional investors own 2.4% of Artelo Biosciences's shares and insiders 0.11%. The largest holder is Jane Street Group LLC with 1.35% of the shares (66K), as of June 30, 2026. Among the top 18 institutions, 8 added shares and 7 reduced their stake in the latest filings. Short interest is 8.43% of the float, or 0.04 days of average trading volume. The share count rose 9,250.0% since 2014.
Related: ARTL analyst forecast, ARTL key metrics. See the ARTL stock overview for the latest quote and news.
ARTL ownership FAQ
Who owns the most Artelo Biosciences stock?
The largest shareholders of Artelo Biosciences are Jane Street Group LLC (1.35%), Geode Capital Management, LLC (0.28%), StoneX Group Inc (0.25%), Vanguard Capital Management, LLC (0.21%), Tower Research Capital LLC (0.17%).
What percentage of Artelo Biosciences is owned by institutions?
Institutions hold 2.4% of Artelo Biosciences's shares outstanding; insiders hold 0.11%.
Which funds own Artelo Biosciences?
The largest fund holders of Artelo Biosciences are Fidelity Extended Market Index (0.03%), Fidelity Series Total Market Index (<0.01%).
What is Artelo Biosciences's short interest?
46K shares of Artelo Biosciences were sold short, 8.43% of the float; at the average daily volume it would take 0.04 days to cover.
Are insiders buying or selling Artelo Biosciences?
Of the latest 1 reported insider transactions in Artelo Biosciences (since August 11, 2022), 1 were purchases and 0 were sales.
How many shares of Artelo Biosciences are outstanding?
Artelo Biosciences has 548K shares outstanding, of which 510K are in the public float.